CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Capital Com Australia Pty Ltd Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (Regulated by NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (Regulated by FSA) Capital Com Online Investments Ltd (Regulated by SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Anda juga dapat menghubungi kami: hubungi +44 2030978888 support@capital.com

Perdagangan BIOLASE - BIOL CFD

4.30
5.07%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.14
Biaya inap posisi Long

Long position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.024068%
Biaya inap posisi short

Short position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
0.001846%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 4.54
Open* 4.38
1-Year Change* 1.62%
Day's Range* 4.26 - 4.58
52 wk Range 0.35-9.58
Average Volume (10 days) 229.89K
Average Volume (3 months) 11.78M
Market Cap 12.50M
P/E Ratio -100.00K
Shares Outstanding 35.58M
Revenue 46.82M
EPS -3.68
Dividend (Yield %) N/A
Beta 1.44
Next Earnings Date Mar 28, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jun 29, 2022 4.30 -0.08 -1.83% 4.38 4.58 4.22
Jun 28, 2022 4.54 0.32 7.58% 4.22 5.00 4.22
Jun 27, 2022 5.08 0.86 20.38% 4.22 5.19 4.22
Jun 24, 2022 4.47 0.25 5.92% 4.22 4.60 4.22
Jun 23, 2022 4.19 0.12 2.95% 4.07 4.30 4.07
Jun 22, 2022 4.05 -0.27 -6.25% 4.32 4.52 3.99
Jun 21, 2022 4.32 0.04 0.93% 4.28 4.53 4.16
Jun 17, 2022 4.51 0.22 5.13% 4.29 4.51 4.29
Jun 16, 2022 4.17 -0.01 -0.24% 4.18 4.37 4.16
Jun 15, 2022 4.26 0.19 4.67% 4.07 4.26 4.07
Jun 14, 2022 4.26 0.17 4.16% 4.09 4.37 4.09
Jun 13, 2022 4.10 -0.17 -3.98% 4.27 4.34 4.07
Jun 10, 2022 4.56 -0.06 -1.30% 4.62 4.62 4.47
Jun 9, 2022 4.67 0.03 0.65% 4.64 4.76 4.64
Jun 8, 2022 4.63 0.01 0.22% 4.62 4.71 4.59
Jun 7, 2022 4.64 0.02 0.43% 4.62 4.73 4.62
Jun 6, 2022 4.67 0.03 0.65% 4.64 4.79 4.59
Jun 3, 2022 4.82 0.20 4.33% 4.62 4.90 4.62
Jun 2, 2022 4.67 0.04 0.86% 4.63 4.80 4.61
Jun 1, 2022 4.63 -0.15 -3.14% 4.78 4.78 4.57

BIOLASE Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 51.81 46.926 46.155 37.799 22.78 39.188
Revenue 51.81 46.926 46.155 37.799 22.78 39.188
Cost of Revenue, Total 31.502 31.8 29.26 23.511 16.607 22.659
Gross Profit 20.308 15.126 16.895 14.288 6.173 16.529
Total Operating Expense 66.772 64.964 67.04 53.42 41.316 52.605
Selling/General/Admin. Expenses, Total 27.471 26.43 29.892 25.144 21.014 26.597
Research & Development 7.799 6.229 5.203 4.765 3.695 6.048
Unusual Expense (Income) 0 0.505 2.685 0 0 -2.699
Operating Income -14.962 -18.038 -20.885 -15.621 -18.536 -13.417
Interest Income (Expense), Net Non-Operating -0.258 0.605 -0.568 -2.278 -2.38 -2.676
Net Income Before Taxes -15.22 -17.433 -21.453 -17.899 -16.701 -16.093
Net Income After Taxes -15.371 4.249 -22.116 -17.855 -16.829 -16.158
Net Income Before Extra. Items -15.371 4.249 -22.116 -17.855 -16.829 -16.158
Net Income -15.371 -16.851 -21.516 -17.855 -16.829 -16.158
Total Adjustments to Net Income -2.184 -3.978 0 0 -17.378 -0.546
Income Available to Common Excl. Extra. Items -17.555 0.271 -22.116 -17.855 -34.207 -16.704
Income Available to Common Incl. Extra. Items -17.555 -20.829 -21.516 -17.855 -34.207 -16.704
Diluted Net Income -17.555 -20.829 -21.516 -17.855 -34.207 -16.704
Diluted Weighted Average Shares 0.48531 0.59007 0.82352 0.92804 2.44544 5.90984
Diluted EPS Excluding Extraordinary Items -36.1726 0.45927 -26.8554 -19.2395 -13.9881 -2.82647
Diluted Normalized EPS -36.1726 1.01555 -24.7362 -19.2395 -13.9881 -3.12332
Total Extraordinary Items -21.1 0.6
Other, Net 4.215 0
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 8.116 9.134 9.531 12.408 10.166
Revenue 8.116 9.134 9.531 12.408 10.166
Cost of Revenue, Total 5.375 5.093 4.689 7.502 5.437
Gross Profit 2.741 4.041 4.842 4.906 4.729
Total Operating Expense 14.178 9.403 12.188 16.838 14.372
Selling/General/Admin. Expenses, Total 7 6.09 5.93 7.669 7.391
Research & Development 1.803 1.162 1.54 1.542 1.544
Operating Income -6.062 -0.269 -2.657 -4.43 -4.206
Interest Income (Expense), Net Non-Operating -0.779 -0.513 -0.605 -0.777 -0.553
Net Income Before Taxes -6.841 -0.782 -3.262 -5.207 -4.759
Net Income After Taxes -6.901 -0.702 -3.276 -5.279 -4.776
Net Income Before Extra. Items -6.901 -0.702 -3.276 -5.279 -4.776
Net Income -6.901 -0.702 -3.276 -5.279 -4.776
Total Adjustments to Net Income -0.532 -0.006 -0.009 0 -0.217
Income Available to Common Excl. Extra. Items -7.433 -0.708 -3.285 -5.279 -4.993
Income Available to Common Incl. Extra. Items -7.433 -0.708 -3.285 -5.279 -4.993
Diluted Net Income -7.433 -0.708 -3.285 -5.279 -4.993
Diluted Weighted Average Shares 5.38344 6.0266 6.07764 6.14228 6.159
Diluted EPS Excluding Extraordinary Items -1.38072 -0.11748 -0.54051 -0.85945 -0.81068
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -1.38072 -0.43479 -0.5374 -0.84622 -0.81068
Unusual Expense (Income) -2.942 0.029 0.125
Other, Net 0 0
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 33.987 36.05 33.307 27.019 35.11 49.354
Cash and Short Term Investments 8.924 11.645 8.044 5.789 17.564 29.972
Cash & Equivalents 8.924 11.645 8.044 5.789 17.564 29.972
Total Receivables, Net 9.784 10.124 11.112 8.76 3.059 4.238
Accounts Receivable - Trade, Net 9.699 10.047 10.99 8.76 3.059 4.238
Total Inventory 13.523 12.298 12.248 10.995 11.157 12.929
Prepaid Expenses 1.505 1.732 1.591 1.163 3.018 2.012
Other Current Assets, Total 0.251 0.251 0.312 0.312 0.312 0.203
Total Assets 41.941 42.984 38.516 31.847 41.025 55.284
Property/Plant/Equipment, Total - Net 4.478 3.674 1.975 1.469 2.758 2.784
Property/Plant/Equipment, Total - Gross 10.703 11.1 10.319 10.791 10.422 10.833
Accumulated Depreciation, Total -6.225 -7.426 -8.344 -9.322 -7.664 -8.049
Goodwill, Net 2.926 2.926 2.926 2.926 2.926 2.926
Intangibles, Net 0 0 0 0 0 0
Other Long Term Assets, Total 0.55 0.334 0.308 0.433 0.231 0.22
Total Current Liabilities 18.014 13.37 15.967 25.779 11.223 13.844
Accounts Payable 9.125 5.109 5.953 5.332 2.651 3.309
Accrued Expenses 4.768 4.689 6.133 3.79 5.771 6.619
Notes Payable/Short Term Debt 0 0 0 13.466 0 0
Current Port. of LT Debt/Capital Leases 0.159 0
Other Current Liabilities, Total 3.962 3.572 3.881 3.191 2.801 3.916
Total Liabilities 19.876 13.724 27.427 27.505 30.997 30.076
Total Long Term Debt 0 0 10.836 0 16.186 13.603
Capital Lease Obligations 0
Deferred Income Tax 0.798 0.104 0.077 0.078
Other Liabilities, Total 1.064 0.25 0.547 1.648 3.588 2.629
Total Equity 22.065 29.26 11.089 4.342 10.028 25.208
Common Stock 0.068 0.102 0.021 0.031 0.098 0.154
Additional Paid-In Capital 201.198 224.91 228.43 235.594 261.573 293.177
Retained Earnings (Accumulated Deficit) -178.325 -195.176 -216.692 -234.547 -251.376 -267.534
Other Equity, Total -0.876 -0.576 -0.67 -0.701 -0.385 -0.623
Total Liabilities & Shareholders’ Equity 41.941 42.984 38.516 31.847 41.025 55.284
Total Common Shares Outstanding 0.54053 0.81872 0.8429 1.25756 3.90654 6.14704
Long Term Debt 10.836 0 16.186 13.603
Redeemable Preferred Stock 3.965
Total Preferred Shares Outstanding 0.07 0 0
Preferred Stock - Non Redeemable, Net 0.118 0.034
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 57.749 55.34 52.654 49.354 43.783
Cash and Short Term Investments 40.842 37.081 33.385 29.972 21.606
Cash & Equivalents 40.842 37.081 33.385 29.972 21.606
Total Receivables, Net 3.266 3.819 3.637 4.238 5.18
Accounts Receivable - Trade, Net 3.266 3.819 3.637 4.238 5.18
Total Inventory 11.877 12.715 14.062 12.929 14.611
Prepaid Expenses 1.56 1.521 1.366 2.012 2.183
Other Current Assets, Total 0.204 0.204 0.204 0.203 0.203
Total Assets 63.484 61.249 58.514 55.284 50.242
Property/Plant/Equipment, Total - Net 2.583 2.758 2.712 2.784 3.302
Property/Plant/Equipment, Total - Gross 10.324 10.587 10.643 10.833 11.469
Accumulated Depreciation, Total -7.741 -7.829 -7.931 -8.049 -8.167
Goodwill, Net 2.926 2.926 2.926 2.926 2.926
Other Long Term Assets, Total 0.226 0.225 0.222 0.22 0.231
Total Current Liabilities 11.27 12.719 13.457 13.844 13.112
Accounts Payable 3.072 3.502 3.597 3.309 4.643
Accrued Expenses 5.386 5.174 4.929 6.619 5.167
Notes Payable/Short Term Debt 0 0.7 0 0 0
Other Current Liabilities, Total 2.812 3.343 3.531 3.916 3.302
Total Liabilities 29.968 27.993 28.192 30.076 29.642
Total Long Term Debt 16.295 12.703 12.114 13.603 13.666
Long Term Debt 16.295 12.703 12.114 13.603 13.666
Other Liabilities, Total 2.403 2.571 2.621 2.629 2.864
Total Equity 33.516 33.256 30.322 25.208 20.6
Preferred Stock - Non Redeemable, Net 0.036 0.035 0.034 0.034 0
Common Stock 0.149 0.151 0.153 0.154 0.155
Additional Paid-In Capital 292.141 292.517 292.948 293.177 293.419
Retained Earnings (Accumulated Deficit) -258.277 -258.979 -262.255 -267.534 -272.31
Other Equity, Total -0.533 -0.468 -0.558 -0.623 -0.664
Total Liabilities & Shareholders’ Equity 63.484 61.249 58.514 55.284 50.242
Total Common Shares Outstanding 5.97652 6.04944 6.13108 6.14704 6.176
Total Preferred Shares Outstanding 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 1.4
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line -15.371 -16.851 -21.516 -17.855 -16.829 -16.158
Cash From Operating Activities -10.596 -18.412 -14.147 -12.746 -12.795 -16.71
Cash From Operating Activities 1.048 1.203 0.945 0.982 0.499 0.4
Deferred Taxes 0.06 -0.694 -0.027 0.007
Non-Cash Items 3.147 3.333 6.46 5.228 1.781 0.985
Cash Taxes Paid 0.076 0.164 0.044 0.035 0.022 0.171
Cash Interest Paid 0.004 0.001 0.023 1.784 1.881 1.771
Changes in Working Capital 0.52 -5.403 -0.009 -1.108 1.754 -1.937
Cash From Investing Activities -1.414 -0.747 -0.522 -0.207 -0.096 -0.707
Capital Expenditures -1.414 -0.747 -0.558 -0.207 -0.096 -0.707
Other Investing Cash Flow Items, Total 0 0 0.036 0
Cash From Financing Activities 9.35 21.618 11.235 10.721 24.349 29.954
Financing Cash Flow Items 0 0 -1.222 -0.954 -3.049 -1.135
Issuance (Retirement) of Stock, Net 9.521 21.764 0.003 9.175 24.958 31.114
Issuance (Retirement) of Debt, Net -0.171 -0.146 12.454 2.5 2.44 -0.025
Foreign Exchange Effects -0.064 0.262 -0.106 -0.023 0.317 -0.238
Net Change in Cash -2.724 2.721 -3.54 -2.255 11.775 12.299
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line -6.901 -7.603 -10.879 -16.158 -4.776
Cash From Operating Activities -6.499 -10.008 -13.606 -16.71 -8.021
Cash From Operating Activities 0.085 0.176 0.281 0.4 0.117
Deferred Taxes 0
Non-Cash Items 1.118 -1.461 -1.035 0.985 0.42
Cash Taxes Paid 0.01 0.13 0.154 0.171 0.026
Cash Interest Paid 0.448 0.886 1.328 1.771 0.377
Changes in Working Capital -0.801 -1.12 -1.973 -1.937 -3.782
Cash From Investing Activities -0.008 -0.311 -0.396 -0.707 -0.304
Capital Expenditures -0.008 -0.311 -0.396 -0.707 -0.304
Cash From Financing Activities 29.825 29.811 29.886 29.954 0
Financing Cash Flow Items -0.006 -0.006 -0.006 -1.135 0
Issuance (Retirement) of Stock, Net 29.831 29.841 29.917 31.114 0
Foreign Exchange Effects -0.148 -0.083 -0.171 -0.238 -0.041
Net Change in Cash 23.17 19.409 15.713 12.299 -8.366
Issuance (Retirement) of Debt, Net -0.024 -0.025 -0.025

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group
500000+

Trader

92000+

Klien aktif per bulan

$53000000+

Volume investasi per bulan

$30000000+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Past performance is not a reliable indicator of future results
Laba/Loss
Industry: Advanced Medical Equipment & Technology (NEC)

27042 Towne Centre Drive
Suite 270
FOOTHILL RANCH
CALIFORNIA 92610
US

Income Statement

  • Annual
  • Quarterly

People also watch

Oil - Crude

67.01 Price
-0.960% 1D Chg, %
Biaya inap posisi Long -0.0221%
Biaya inap posisi short 0.0002%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

XRP/USD

0.39 Price
+2.420% 1D Chg, %
Biaya inap posisi Long -0.0753%
Biaya inap posisi short 0.0069%
Waktu biaya inap 21:00 (UTC)
Spread 0.00393

BTC/USD

27,635.85 Price
-1.770% 1D Chg, %
Biaya inap posisi Long -0.0616%
Biaya inap posisi short 0.0137%
Waktu biaya inap 21:00 (UTC)
Spread 60.00

US100

12,592.90 Price
+0.230% 1D Chg, %
Biaya inap posisi Long -0.0241%
Biaya inap posisi short 0.0018%
Waktu biaya inap 21:00 (UTC)
Spread 1.8

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda